Company profile: Trividia Health
1.1 - Company Overview
Company description
- Provider of advanced blood glucose monitoring supplies and technologies for people with diabetes, including self-monitoring systems (TRUE METRIX, TRUE METRIX AIR, TRUE METRIX GO), a self-check glycated hemoglobin test (TRUE+A1CNow), and data management software (TRUEmanager, TRUE MANAGER AIR). Develops, manufactures and markets products for testing, results review and trend reporting.
Products and services
- TRUE METRIX AIR: Bluetooth-enabled self-monitoring blood glucose system with no coding, rapid test times, small sample size requirements, and onboard data storage for convenient tracking
- TRUE+A1CNow: Capillary blood-based self-check test system measuring glycated hemoglobin (A1C) and producing results in 5 minutes from a small blood sample
- TRUE METRIX: Self-monitoring blood glucose system featuring no coding, fast results, small sample size, alternate site testing capability, and integrated data storage
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Trividia Health
Fractyl Health
HQ: United States
Website
- Description: Provider of curative therapies for metabolic diseases, including Revita, a therapy designed to modify duodenal dysfunction via hydrothermal ablation to restore metabolic health, and Rejuva, a preclinical AAV gene therapy platform aimed at improving islet function for long-term remission of T2D and obesity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Fractyl Health company profile →
Satiogen
HQ: United States
Website
- Description: Provider of specialty pharmaceutical therapies targeting type 2 diabetes, offering metabolic mechanism therapy designed to regulate nutrient intake and postprandial glucose. Products include a substitute for metformin in gliptin formulations and an OTC nutraceutical.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Satiogen company profile →
PTS Diagnostics
HQ: United States
Website
- Description: Provider of point-of-care diagnostic devices and supplies delivering lipid, glucose, and A1C results from small blood samples, including CardioChek Plus and CardioChek PA analyzers, A1CNow+, CardioChek Home Cholesterol Test System, PTS Panels test strips, and PTS Collect capillary tubes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PTS Diagnostics company profile →
Calibrium
HQ: United States
Website
- Description: Provider of biopharmaceutical research and development, focused on developing a portfolio of novel drug candidates for the treatment of diabetes and related metabolic diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Calibrium company profile →
Animas
HQ: United States
Website
- Description: Provider of external insulin pumps for people with diabetes, designing, developing, manufacturing, and selling these devices. Believed to be the second-largest supplier in the U.S. by new pump placements. Introduced the R1000 in July 2000 and expects to begin shipping its third-generation pump.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Animas company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Trividia Health
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Trividia Health
2.2 - Growth funds investing in similar companies to Trividia Health
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Trividia Health
4.2 - Public trading comparable groups for Trividia Health
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →